Vaccine for rare, but deadly mosquito-borne viruses shows promise in clinical trial
The study has appeared online in "The Lancet Infectious Diseases"
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NIAID
NIH launches clinical trial of three mRNA HIV vaccines
Phase-I study is amongst the first to examine mRNA technology for HIV
NIH launches trial to study allergic reactions to COVID-19 mRNA vaccine
The trial is seeking participants who experienced a mild or moderate systemic allergic reaction following the first dose of either…
Experimental mRNA HIV vaccine shows promise in animals
Their results, published in Nature Medicine, show that the novel vaccine was safe and prompted desired antibody and cellular…
NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease
Trial also will test pausing immunosuppressive medication to improve antibody response
Antibody levels predictive of Moderna’s vaccine efficacy, says study
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high…
NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients
The trial will assess antibody response in people who did not respond to two-dose regimen
Moderna commences trial of COVID-19 vaccine in children
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to…
US FDA Advisory Committee supports EUA for Moderna’s COVID-19 vaccine
The primary analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1 per cent
EMA begins rolling review of Moderna’s COVID-19 vaccine candidate
Moderna also announced a supply agreement with the UK government to supply mRNA-1273, if approved for use by MHRA